Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on ferroptosis in gliomas (Review). | Oncol Lett | 2024 | 38108075 | PubTator, text mining | PubMed |
| BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility. | Nat Microbiol | 2024 | 38066332 | PubTator, text mining | PubMed |
| A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study. | Cancer Rep (Hoboken) | 2024 | 38043920 | PubTator, text mining | PubMed |
α-Pyrrolidinononanophenone derivatives induce differentiated SH-SY5Y neuroblastoma cell apoptosis via reduction of antioxidant capacity: Involvement of NO depletion and inactivation of Nrf2/HO1 signaling pathway. | Neurotoxicology | 2024 | 38040126 | PubTator, text mining | PubMed |
| Circ_0005015 upregulates BACH1 to promote aggressive behaviors in glioblastoma by sponging microRNA-382-5p. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38032493 | PubTator, text mining | PubMed |
| Zika virus restriction of host antioxidant response is mediated by intracellular NS1 and reveals its ability to upregulate Bach1 expression. | Biochem Biophys Res Commun | 2024 | 38016247 | PubTator, text mining | PubMed |
| Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney disease. | Kidney Int | 2024 | 37925023 | PubTator, text mining | PubMed |
| Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives. | Bioessays | 2024 | 37919861 | PubTator, text mining | PubMed |
| Evaluation of Rapanone and Nectandrin B as novel inhibitors for targeting the metastatic regulator protein BACH1 using breast cancer cell line Mcf-7. | J Biomol Struct Dyn | 2024 | 37747058 | PubTator, text mining | PubMed |
| Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis. | Ann Rheum Dis | 2024 | 37657927 | PubTator, text mining | PubMed |
| Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors. | Blood Cells Mol Dis | 2024 | 37633023 | PubTator, text mining | PubMed |
| Physiological and pathological functions of circular RNAs in the nervous system. | Neural Regen Res | 2024 | 37488888 | PubTator, text mining | PubMed |
| Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. | Front Genet | 2023 | 38259614 | PubTator, text mining | PubMed |
| The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections. | Pathogens | 2023 | 38251346 | PubTator, text mining | PubMed |
| PCR Array Profiling of miRNA Expression Involved in the Differentiation of Amniotic Fluid Stem Cells toward Endothelial and Smooth Muscle Progenitor Cells. | Int J Mol Sci | 2023 | 38203477 | PubTator, text mining | PubMed |
| BRCA Mutations and Fertility Preservation. | Int J Mol Sci | 2023 | 38203374 | PubTator, text mining | PubMed |
| The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. | Molecules | 2023 | 38202657 | PubTator, text mining | PubMed |
| Is Environmental Cadmium Exposure Causally Related to Diabetes and Obesity? | Cells | 2023 | 38201287 | PubTator, text mining | PubMed |
| Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma. | Front Immunol | 2023 | 38187398 | PubTator, text mining | PubMed |
| An impaired ubiquitin-proteasome system increases APOBEC3A abundance. | NAR Cancer | 2023 | 38155930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=13